@genethonfr.bsky.social
Avec plus de 240 scientifiques et professionnels, Généthon a pour objectif de mettre au point des thérapies innovantes qui changent la vie des patients souffrant de maladies génétiques rares.
www.genethon.fr
@genethonfr.bsky.social📆First day of the #CGMESA26 ! We look forward to seeing everyone this week.
Don’t miss @genethonfr.bsky.social activities presentation by Imen Mestiri, PhD, Business Development and Licensing Lead October 5th at 9:30 am to 9:45 am, FLW Ballroom F.
@genethonfr.bsky.social@genethonfr.bsky.social is registered to attend
@alliancerm.bsky.social
#CGMesa26!
Can't wait to dive into discussions, network with industry leaders, and explore the latest advancements in #cellandgenetherapy.
Let the countdown begin!
See you in Phoenix! 🌵🧬
@genethonfr.bsky.social📢 #WMS2026 Sept. 30
🎙️ Oral Session 3 (3:30–4:00 PM)
Mario Amendola: CRISPR-based utrophin upregulation for Duchenne muscular dystrophy
Vincent Laugel: Long-term Phase 1/2 results of GNT0004 gene therapy
📄 3 posters from @genethonfr.bsky.social
(5:15–6:15 PM)
